Access Policy Counsel · Since 1997
Omega Arastirma offers boutique consultancy services in the field of market access, building on experience that goes back to 1997.
1997
Founded
29+
Years of Experience
54
References
23+
Model Adaptations
Value-Added
Omega Arastirma conducts Policy Studies for Market Access in order to make a positive contribution to evaluation by explaining the therapeutic area/disease, ind...
More Information
Provides consultancy service on the development of alternative study models which will positively support the reimbursement evaluation decisions of innovative d...
More Information
It provides consultancy service for the determination of reimbursement application strategy in different therapeutic areas, diseases and indications, preparatio...
More Information
The pharmacoeconomic model developed globally is updated with local data and its adaptation for Türkiye and reporting are carried out.
More Information
Focus group studies are carried out with experts consisting of local data supply for model adaptation, prevalence and incidence analysis, patient number analysi...
More Information
Corporate and customized training services are offered to pharmaceutical, medical material and device companies, non-governmental organizations and public insti...
More Information
Consultancy services are offered in a wide range, from the preparation plan before patent expiry to competition strategies in the generic environment.
More Information
It enables the sector to benefit from digital health technologies by developing configurable platforms for healthcare managers and decision makers and user-frie...
More Information
Social Responsibility Programs are designed by Omega Arastirma to accelerate patients' access to innovative medicines.
More Information
It provides consultancy service for the licensing, pricing, reimbursement evaluation and decision-making process, market analysis, evaluation of specific market...
More Information
Consultancy services are offered in externally funded national and international projects, support to health authorities and capacity building.
More InformationProcess
1
We listen to your needs, scope the therapeutic area, indication and product, and define the roadmap together.
2
Local data collection, expert opinion, advisory boards and analysis according to the phases of the selected service.
3
Final report, reimbursement file sections and management of the evaluation process until the decision.
Trust
